Evidence map›Paper›PMID 41827209›Full record

ReviewJournal of clinical medicine2026

Minoxidil Beyond Hair: A Comprehensive Review of Its Effects on Nail Growth.

Víctor Pinos-León, Jorge Vasconez-Gonzalez, Juan S Izquierdo-Condoy, Belén Pazmiño, Jenny Sánchez, Vianca Torres, Esteban Ortiz-Prado

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Víctor Pinos-LeónGrupo Derma AID, Quito 170103, Ecuador.
Jorge Vasconez-GonzalezOne Health Research Group, Faculty of Health Science, Universidad de Las Americas, Ecuador Calle de los Colimes y Avenida De los Granados, Quito 170137, Ecuador.
Juan S Izquierdo-CondoyOne Health Research Group, Faculty of Health Science, Universidad de Las Americas, Ecuador Calle de los Colimes y Avenida De los Granados, Quito 170137, Ecuador.ORCID 0000-0002-1178-0546
Belén PazmiñoGrupo Derma AID, Quito 170103, Ecuador.
Jenny SánchezGrupo Derma AID, Quito 170103, Ecuador.
Vianca TorresOne Health Research Group, Faculty of Health Science, Universidad de Las Americas, Ecuador Calle de los Colimes y Avenida De los Granados, Quito 170137, Ecuador.
Esteban Ortiz-PradoOne Health Research Group, Faculty of Health Science, Universidad de Las Americas, Ecuador Calle de los Colimes y Avenida De los Granados, Quito 170137, Ecuador.ORCID 0000-0002-1895-7498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minoxidil is a well-established treatment for hair loss, known for its vasodilatory properties and effects on dermal papilla cells. Recently, interest has emerged regarding its potential role in promoting nail growth, both in healthy individuals and in those with nail dystrophies. The objective of this review was to synthesize and critically analyze the available evidence on the effects of topical and oral minoxidil on nail growth, including proposed mechanisms of action, clinical outcomes, and safety. A narrative literature review was conducted using studies published in indexed journals that evaluated the pharmacological effects of minoxidil on the nail unit. Mechanistic data were extracted from in vitro and in vivo models, while clinical results were compiled from pilot studies, case reports, and trials evaluating nail growth in both healthy and pathologic conditions. Proposed mechanisms include vasodilation, increased VEGF expression, and hypothesized involvement of pro-growth pathways (e.g., Wnt/β-catenin), largely extrapolated from hair follicle biology; direct nail-matrix-specific mechanistic evidence remains limited. Clinical studies with 5% topical minoxidil have shown increases in nail growth rate ranging from 13% to 19% over 28 days, while oral minoxidil (2.5 mg) resulted in an approximately 50% increase in nail growth speed in small studies. Evidence also suggests improvements in nail strength and appearance. Adverse effects were minimal, with no significant changes in blood pressure and only modest increases in heart rate with oral formulations. Although evidence remains limited, preliminary findings suggest a potential role for minoxidil in enhancing nail growth, particularly in cases of slowed growth or nail dystrophy. More robust, large-scale studies are needed to confirm efficacy, determine optimal formulations, and establish long-term safety. Given its accessibility and tolerability, minoxidil may represent a promising off-label adjunct for nail growth modulation.

Indexed as

minoxidilnail growthoral minoxidiltopical formulationvascular endothelial growth factorWnt signaling

Identifiers

PMID41827209
PMCPMC12986142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.